Warning
Rising Pharma Holding Recalls Rising
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0724-2026Drug / Pharmaceutical
Rising Pharma Holding Recalls Rising
Rising Pharma Holding, Inc. · Class II — Moderate Risk
Product Description
Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.
Reason for Recall
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide U.S.A.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A Class II FDA recall has been issued for a pharmaceutical product from Rising Pharma Holding, Inc., initiated on July 13, 2026. Presence of Precipitate: medication was crystallizing and particles floating in the bottle. This recall covers 74208 units, distributed nationwide. While not the highest severity, consumers should exercise caution and stop using the product until the recall is resolved.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.